JAC Advance Access originally published online on July 8, 2005
Journal of Antimicrobial Chemotherapy 2005 56(3):447-450; doi:10.1093/jac/dki249
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leading article |
Mechanisms of resistance to telithromycin in Streptococcus pneumoniae
1 Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; 2 Department of Clinical Microbiology, Health Sciences Centre, MS673-820 Sherbrook Street, Winnipeg, Manitoba, R3A 1R9, Canada; 3 Department of Medicine, Health Sciences Centre, MS673-820 Sherbrook Street, Winnipeg, Manitoba, R3A 1R9, Canada
* Corresponding author. Tel: +1-204-787-4684; Fax: +1-204-787-4699; E-mail: thisanaga{at}shaw.ca
Reports of ketolide resistance remain scarce, however, a few laboratory-derived and clinical isolates of resistant Streptococcus pneumoniae have been documented. Mutations in key telithromycin-binding sites such as domains II and V of the 23S rRNA and ribosomal proteins L4 and L22, as well as mutations of the resistance determinant erm(B) are associated with elevated telithromycin MICs. Mutations in the secondary binding site of domain II coupled with ribosomal methylation may have serious resistance consequences should the domain II binding site be lost. Although ketolides are purported to maintain excellent activity against efflux-positive isolates, laboratory-derived telithromycin-resistant strains have been generated. As telithromycin usage increases, ketolide-resistant isolates of S. pneumoniae may well increase.
Keywords: mutations , 23S rRNA , mef(A) , erm(B)
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. R. Gentry and D. J. Holmes Selection for High-Level Telithromycin Resistance in Staphylococcus aureus Yields Mutants Resulting from an rplB-to-rplV Gene Conversion-Like Event Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1156 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Al-Lahham, P. C. Appelbaum, M. van der Linden, and R. R. Reinert Telithromycin-Nonsusceptible Clinical Isolates of Streptococcus pneumoniae from Europe Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3897 - 3900. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dias, D. Louro, the Antimicrobial Resistance Surveillance Program, and M. Canica Antimicrobial Susceptibility of Invasive Streptococcus pneumoniae Isolates in Portugal over an 11-Year Period. Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2098 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rantala, M. Haanpera-Heikkinen, M. Lindgren, H. Seppala, P. Huovinen, J. Jalava, and the Finnish Study Group for Antimicrobial Resistan Streptococcus pneumoniae Isolates Resistant to Telithromycin. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1855 - 1858. [Abstract] [Full Text] [PDF] |
||||
